Adiponectin prevents atherosclerosis by inhibiting the expression of monocyte adhesion molecules and endothelial synthesis of pro-inflammatory chemokine by inactivating nuclear factor-kappaB [31, 32] as well as suppressing proliferation of vascular smooth muscle cells by targeting extracellular signal-regulated kinase [33]. Here, ADIPOQ is linked to atherosclerosis.